Related Experiment Video
Updated: Jul 3, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer
Ines Macias-Perez1, Corina Borza, Xiwu Chen
1Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center, Veterans Affairs Hospital, Nashville, Tennessee 37232, USA.
Abstract:
The collagen IV binding receptor integrin alpha1beta1 has been shown to regulate lung cancer due to its proangiogenic properties; however, it is unclear whether this receptor also plays a direct role in promoting primary lung tumors. To investigate this possibility, integrin alpha1-null mice were crossed with KrasLA2 mice that carry an oncogenic mutation of the Kras gene (G12D) and develop spontaneous primary tumors with features of non-small cell lung cancer. We provide evidence that KrasLA2/alpha1-null mice have a decreased incidence of primary lung tumors and longer survival compared with KrasLA2/alpha1 wild-type controls. Tumors from KrasLA2/alpha1-null mice were also smaller, less vascularized, and exhibited reduced cell proliferation and increased apoptosis, as determined by proliferating cell nuclear antigen and terminal deoxynucleotidyl-transferase-mediated dUTP nick-end staining, respectively. Moreover, tumors from the KrasLA2/alpha1-null mice showed diminished extracellular signal-regulated kinase (ERK) but enhanced p38 mitogen-activated protein kinase activation. Primary lung tumor epithelial cells isolated from KrasLA2/alpha1-null mice showed a significant decrease in anchorage-independent colony formation, collagen-mediated cell proliferation, ERK activation, and, most importantly, tumorigenicity when injected into nude mice compared with KrasLA2/alpha1 wild-type tumor cells. These results indicate that loss of the integrin alpha1 subunit decreases the incidence and growth of lung epithelial tumors initiated by oncogenic Kras, suggesting that both Kras and integrin alpha1beta1 cooperate to drive the growth of non-small cell lung cancer in vivo.
Insights
Integrin alpha1beta1 promotes non-small cell lung cancer growth. Loss of integrin alpha1 reduces lung tumor incidence and progression in Kras-driven mouse models, indicating a cooperative role in cancer development.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Integrin alpha1beta1, a collagen IV binding receptor, is implicated in lung cancer via proangiogenic effects.
- Its direct role in primary lung tumor promotion remains largely uncharacterized.
Purpose of the Study:
- To investigate the direct role of integrin alpha1beta1 in promoting primary lung tumors initiated by oncogenic Kras.
- To elucidate the molecular mechanisms underlying integrin alpha1's function in non-small cell lung cancer (NSCLC) development.
Main Methods:
- Crossed integrin alpha1-null mice with KrasLA2 mice (carrying oncogenic Kras G12D mutation) to generate KrasLA2/alpha1-null and control littermates.
- Assessed tumor incidence, survival, vascularization, proliferation (PCNA), apoptosis (TUNEL), and kinase activation (ERK, p38 MAPK).
- Evaluated anchorage-independent colony formation, collagen-mediated proliferation, ERK activation, and tumorigenicity of isolated tumor cells in vivo.
Main Results:
- KrasLA2/alpha1-null mice exhibited decreased primary lung tumor incidence and prolonged survival compared to controls.
- Tumors in KrasLA2/alpha1-null mice were smaller, less vascularized, with reduced proliferation and increased apoptosis.
- Loss of integrin alpha1 diminished ERK activation but enhanced p38 MAPK activation, and reduced tumor cell tumorigenicity and proliferation.
Conclusions:
- Loss of the integrin alpha1 subunit significantly decreases the incidence and growth of lung epithelial tumors initiated by oncogenic Kras.
- Integrin alpha1beta1 and oncogenic Kras cooperate to drive the progression of non-small cell lung cancer in vivo.
- Targeting integrin alpha1beta1 may represent a therapeutic strategy for NSCLC.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity: